Breadcrumb Navigation:

Home > About the Society

About the Society

The National MS Society is a collective of passionate individuals who want to do something about MS now—to move together toward a world free of multiple sclerosis. MS stops people from moving. We exist to make sure it doesn't.

We help each person address the challenges of living with MS through our 50-state network of chapters. The Society helps people affected by MS by funding cutting-edge research, driving change through advocacy, facilitating professional education, and providing programs and services that help people with MS and their families move their lives forward.

  • We are moving research forward by relentlessly pursuing prevention, treatment and cure.
  • We are moving to reach out and respond to individuals, families and communities living with multiple sclerosis.
  • We are moving politicians and legislation to champion the needs of people with MS through activism, advocacy and influence.
  • We are moving to mobilize the millions of people who want to do something about MS now.

JOIN THE MOVEMENT

News About the Society

Fast Forward, LLC, Announces $1 Million Sponsored Research Agreement to Fund Proof of Principle Clinical Trial for Therapeutic Vaccine

Dec 23, 2008
Fast Forward, LLC, the National Multiple Sclerosis Society’s subsidiary devoted to bridging the gap between research and drug development, has announced a partnership to support Apitope International NV, the autoimmune peptide therapy company, in its proof of principle clinical trial of ATX-MS-1467. This peptide therapeutic vaccine is designed to target and prevent the abnormal pathological immune response in multiple sclerosis (MS).

Great Strides Moved MS Research Forward During 2008

Dec 02, 2008
The year saw rapid research progress in virtually every field of science and medicine that impacts our understanding of the unpredictable neurological disease of multiple sclerosis. Significant advances have been made in both clinical and laboratory studies in MS. In addition, more than 130 clinical trials are underway around the world – with over one dozen final-phase trials of new therapies including some taken by mouth.

Young MS Researchers Shine at First-Ever Tykeson Fellows Conference on MS

Dec 02, 2008
The first-ever Tykeson Fellows Conference on MS was indeed a meeting of the minds -- young scientists beginning their careers in MS research, established investigators sharing their expertise, and – because it was held in conjunction with the National MS Society’s 2008 National Conference – the hopes and purpose brought to the table by people with MS.